Recombinant Saccharomyces cerevisiae CDC19 Protein (Yeast)，His

CDC19, also known as cyclin-dependent kinase 19, is a crucial protein in the regulation of the cell cycle, particularly in the transition between different phases of cell division. It belongs to the family of cyclin-dependent kinases (CDKs) that play essential roles in controlling cellular proliferation and ensuring proper cell cycle progression. The study of CDC19 recombinant protein has gained attention due to its significant implications in cancer research, where dysregulation of CDK activity often leads to uncontrolled cell growth. Researchers have focused on characterizing CDC19's structure, function, and interaction with various cyclins and other regulatory proteins. Understanding the mechanisms by which CDC19 operates can provide insights into its role in normal cell cycle regulation and how its aberrations contribute to oncogenesis. Moreover, the development of CDC19 inhibitors has emerged as a promising therapeutic strategy for treating specific cancers. By producing CDC19 as a recombinant protein, scientists can explore its biochemical properties, evaluate potential inhibitors, and assess the protein's functionality in vitro, paving the way for novel cancer therapies. Through these studies, CDC19 is positioned as an important target for drug discovery and a vital component in the ongoing efforts to develop effective cancer treatment strategies.